Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
Learn MoreFresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
Learn MoreThe Conference Call on Q3 takes place on November 4, 2025
Learn MoreWhy I love home dialysis as a HCP working in nephrology
Learn MoreThe Challenges and Benefits of Generative AI in Kidney Care
Learn MoreResearch in brief: Time on treatment
Learn MoreFresenius Medical Care at the American Society of Nephrology (ASN) Kidney Week 2025
Learn More